The Department of Justice and US Drug Enforcement Administration have proposed a reduction for controlled substance that may be manufactured in the US next year. The proposal looks to decrease manufacturing quotas for the six most frequently misused opioids for 2019, by an average of ten percent compared to the 2018 amount. US Attorney for the Eastern District of Kentucky Robert Duncan JR, said illicit diversion of prescription opioids has been a significant catalyst for the epidemic, and it is a critically important area to focus efforts to stem the tide.
DOJ, DEA Propose Reduction to Controlled Substance Manufacturing
Be the first to comment